Here are five insights:
1. The medical device company expects fourth quarter, ending Dec. 31, 2017, sales to reach $175.5 million, a 15.8 percent increase compared to the 2016 fourth quarter.
2. With 12.7 percent in full year sales, Globus Medical anticipates to report $635.4 million in 2017 sales.
3. Globus Medical developed a full year 2018 guidance of $690 million in sales and $1.50 fully diluted non-GAAP earnings per share.
4. The company’s international business sector grew 16.3 percent year-over-year with Japan leading the development.
5. Globus Medical CEO Dave Demski noted the growth as “100 percent organic” and that the U.S. spine sales continue to show mid-single-digit growth.
More articles on devices and implants:
Providence Medical Technology names new executive; reports 2 new studies: 5 insights
Alphatec reports $25M+ in 2017 revenue — 5 points
SeaSpine to see 2017 revenue of $34M+ — 7 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
